Mycoses

Article	Citations
Author Index	51
	47
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	46
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	44
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	43
Physicians' knowledge of invasive fungal disease in China	43
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	41
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	38
Emergence of Candida auris in intensive care units in Algeria	37
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	35
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	35
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	32
Review Article White Piedra: Review of 131 cases	31
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	31
Issue Information	30
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	30
Performance Evaluation of Five Real‐Time PCR Assays for the Detection of Candida aurisDNA	29
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	28
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	28
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	27
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	26
Issue Information	26
Issue Information	26
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	24
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	24

Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	24
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	24
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	24
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	24
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	21
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	21
ESCMID‐EFISG Survey on Diagnostic and Therapeutic Capacity for Invasive Fungal Infections in Belgium, the Netherlands, and Luxembourg: A Focus on High Azole Resistance	20
Cover Image	20
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	20
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	20
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	20
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	19
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	19
	19
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	19
Performance of the RealStar®Pneumocystis jirovecii PCR kit for the diagnosis of Pneumocystis pneumonia	18
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	18
Diagnostic performance of noncultural methods for central nervous system aspergillosis	18
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	18
Issue Information	18
Tinea pedis in underrepresented groups: All of Us database analysis	17
CARD9 mutations in patients with fungal infections: An update from the last 5 years	17
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	17
Species Distinction in the Trichophyton mentagrophytes Complex Based on Phylogenomic Analysis	17
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	17
	16
	16
	16
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	15
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	15
	15
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	15
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	15
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	15
Immune reconstitution inflammatory syndrome in non‐HIV cryptococcal meningitis: Cross‐talk between pathogen and host	15
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	15
Zoonotic and Anthropophilic Trichophyton mentagrophytes Complex Infection in Human: An Update and Narrative Review	14
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	14
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	14
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	14
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	13
The Role of Histopathological Examination in the Diagnosis of Cutaneous Sporotrichosis Caused by Sporothrix globosa: A Retrospective Analysis and Reassessment	13
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	13
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	12
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	12
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	12
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	12
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	12
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	12
Issue Information	12

A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	12
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	12
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	12
	12
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	12
	12
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	12
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	12
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	11
	11
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	11
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	11
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	11
Biologic Therapy and Superficial Fungal Infection Risk in Moderate‐to‐Severe Psoriasis: A Meta‐Analysis	11
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	11
Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India	11
	11
Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	11
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	11
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	11
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections	10
Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis—A Six‐year Retrospective Cohort Study	10
	10
Aspergillus nodules: Natural history and the effect of antifungals	10
	10
Posters	10
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	10
Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study	10
Issue Information	10
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	10
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	10
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	10
Expert recommendations for prevention and management of Candida auris transmission	10
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	10
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	10
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	10
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	9
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	9
Updated estimation of the burden of fungal disease in Vietnam	9
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	9
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	9
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	9
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	9
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	9
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis	9
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France	9
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	9
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	8
Abstracts	8
Coccidioidomycosis in Oklahoma: A retrospective case series	8
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	8
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	8
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	8
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	8
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	8
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	8
Paediatric cutaneous mucormycosis: A case report and review of the literature	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Trichophyton Quinckeanum: Renaissance of the Mouse Favus Pathogen in Central Germany	7
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	7
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	7
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	7
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador	7
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	7
Invasive fungal infections in acute and chronic liver impairment: A systematic review	7
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	7
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	7
Issue Information	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Time and cost‐efficient identification of Trichophyton indotineae	7
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	7
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	7
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	7
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	7
	7
Issue Information	7
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real‐life settings: A nationwide population‐based cohort study	6
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Pr	6
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	6
Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	6

Deep Learning Models for CT Segmentation of Invasive Pulmonary Aspergillosis, Mucormycosis, Bacterial Pneumonia and Tuberculosis: A Multicentre Study	6
Issue Information	6
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	6
Issue Information	6
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment	6
Epidemiological and Clinical Profile Analysis of Trichophyton mentagrophytesITS Genotype VII Infected Dermatomycosis: An Emerging Sexually Transmitted Pathogen	6
	6
	6
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals	6
Genotypic diversity and antifungal susceptibility of Scedosporium species from clinical settings in China	6
Dermatophytes and skin dermatophytoses in Southeast Asia—First epidemiological survey from Cambodia	6
	6
Pharmacies Counselling of Patients in the Era of Antifungal Resistance	6
Increasing and Alarming Prevalence of Trichophyton indotineae as the Primary Causal Agent of Skin Dermatophytosis in Iran	6
A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India	6
Altered skin fungal and bacterial community compositions in tinea capitis	6
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	6
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	6
Immune and metabolic perturbations in COVID‐19‐associated pulmonary mucormycosis: A transcriptome analysis of innate immune cells	6
Issue Information	6
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	6
Airway Mycobiota—Microbiota During Pulmonary Exacerbation of Cystic Fibrosis Patients: A Culture and Targeted Sequencing Study	6